YJWBOMWJPNSWFB-WMZOPIPTSA-N
C23H21F6N5O3 — CID 121266354
Data last refreshed: (MolForge compound catalog, from PubChem)
About YJWBOMWJPNSWFB-WMZOPIPTSA-N
YJWBOMWJPNSWFB-WMZOPIPTSA-N (PubChem CID 121266354) has the molecular formula C23H21F6N5O3 and a molecular weight of 529.44 g/mol. Its IUPAC name is (2S,3S)-3-hydroxy-2-[3-[3-(trifluoromethyl)-4-[2-[4-(trifluoromethyl)phenyl]ethoxy]phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carboximidamide.
Molecular Properties
| Compound Name | YJWBOMWJPNSWFB-WMZOPIPTSA-N |
|---|---|
| PubChem CID | 121266354 |
| Molecular Formula | C23H21F6N5O3 |
| Molecular Weight | 529.44 g/mol |
| Exact Mass | 529.15 |
| IUPAC Name | (2S,3S)-3-hydroxy-2-[3-[3-(trifluoromethyl)-4-[2-[4-(trifluoromethyl)phenyl]ethoxy]phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carboximidamide |
| SMILES | [H]/N=C(\N)N1CC[C@H](O)[C@H]1c1nc(-c2ccc(OCCc3ccc(C(F)(F)F)cc3)c(C(F)(F)F)c2)no1 |
| InChI | InChI=1S/C23H21F6N5O3/c24-22(25,26)14-4-1-12(2-5-14)8-10-36-17-6-3-13(11-15(17)23(27,28)29)19-32-20(37-33-19)18-16(35)7-9-34(18)21(30)31/h1-6,11,16,18,35H,7-10H2,(H3,30,31)/t16-,18-/m0/s1 |
| InChIKey | YJWBOMWJPNSWFB-WMZOPIPTSA-N |
| XLogP | 4.40 |
| TPSA | 121.49 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 529.44 |
| LogP ≤ 5 | 4.40 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121266354 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.